• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PPARs 的翻译为过氧化物酶体增殖物激活受体(peroxisome proliferator-activated receptors),是一类配体激活的转录因子。因此,此句译文为:过氧化物酶体增殖物激活受体(PPARs)的功能调节通过翻译后修饰。

Functional Regulation of PPARs through Post-Translational Modifications.

机构信息

Lee Kong Chian School of Medicine, Nanyang Technological University, 11 Mandalay Road, Singapore 308232, Singapore.

Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), 61 Biopolis Drive, Singapore 138673, Singapore.

出版信息

Int J Mol Sci. 2018 Jun 12;19(6):1738. doi: 10.3390/ijms19061738.

DOI:10.3390/ijms19061738
PMID:29895749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6032173/
Abstract

Peroxisome proliferator-activated receptors (PPARs) belong to the nuclear receptor superfamily and they are essential regulators of cell differentiation, tissue development, and energy metabolism. Given their central roles in sensing the cellular metabolic state and controlling metabolic homeostasis, PPARs became important targets of drug development for the management of metabolic disorders. The function of PPARs is mainly regulated through ligand binding, which induces structural changes, further affecting the interactions with co-activators or co-repressors to stimulate or inhibit their functions. In addition, PPAR functions are also regulated by various Post-translational modifications (PTMs). These PTMs include phosphorylation, SUMOylation, ubiquitination, acetylation, and -GlcNAcylation, which are found at numerous modification sites. The addition of these PTMs has a wide spectrum of consequences on protein stability, transactivation function, and co-factor interaction. Moreover, certain PTMs in PPAR proteins have been associated with the status of metabolic diseases. In this review, we summarize the PTMs found on the three PPAR isoforms PPARα, PPARβ/δ, and PPARγ, and their corresponding modifying enzymes. We also discuss the functional roles of these PTMs in regulating metabolic homeostasis and provide a perspective for future research in this intriguing field.

摘要

过氧化物酶体增殖物激活受体 (PPARs) 属于核受体超家族,是细胞分化、组织发育和能量代谢的重要调节因子。鉴于它们在感知细胞代谢状态和控制代谢稳态方面的核心作用,PPARs 成为代谢紊乱药物开发的重要靶点。PPARs 的功能主要通过配体结合来调节,配体结合诱导结构变化,进一步影响与共激活因子或共抑制因子的相互作用,从而刺激或抑制其功能。此外,PPAR 的功能还受到各种翻译后修饰 (PTMs) 的调节。这些 PTMs 包括磷酸化、SUMO 化、泛素化、乙酰化和 -GlcNAc 化,它们存在于许多修饰位点上。这些 PTMs 的添加对蛋白质稳定性、转录激活功能和共因子相互作用有广泛的影响。此外,PPAR 蛋白中的某些 PTMs与代谢疾病的状态有关。在这篇综述中,我们总结了在三种 PPAR 亚型 PPARα、PPARβ/δ 和 PPARγ 及其相应的修饰酶上发现的 PTMs,并讨论了这些 PTMs 在调节代谢稳态中的功能作用,为这一有趣领域的未来研究提供了一个视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0af3/6032173/b98126cfdc49/ijms-19-01738-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0af3/6032173/9c4731dfc5ca/ijms-19-01738-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0af3/6032173/22e1cc6a796c/ijms-19-01738-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0af3/6032173/de33e880317d/ijms-19-01738-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0af3/6032173/b98126cfdc49/ijms-19-01738-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0af3/6032173/9c4731dfc5ca/ijms-19-01738-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0af3/6032173/22e1cc6a796c/ijms-19-01738-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0af3/6032173/de33e880317d/ijms-19-01738-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0af3/6032173/b98126cfdc49/ijms-19-01738-g004.jpg

相似文献

1
Functional Regulation of PPARs through Post-Translational Modifications.PPARs 的翻译为过氧化物酶体增殖物激活受体(peroxisome proliferator-activated receptors),是一类配体激活的转录因子。因此,此句译文为:过氧化物酶体增殖物激活受体(PPARs)的功能调节通过翻译后修饰。
Int J Mol Sci. 2018 Jun 12;19(6):1738. doi: 10.3390/ijms19061738.
2
Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.过氧化物酶体增殖物激活受体(PPAR)-γ通过对PPAR表达水平的相互调控,在PPARβ/δ上产生汇聚作用,从而正向调控大鼠脑星形胶质细胞中环氧化酶-2的表达,而PPARα则负向调控该表达。
Mol Pharmacol. 2009 Aug;76(2):414-24. doi: 10.1124/mol.109.056010. Epub 2009 May 29.
3
Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons.大鼠皮质神经元中过氧化物酶体增殖物激活受体(PPARs)和视黄酸受体(RXRs)的表达
Neuroscience. 2005;130(2):325-37. doi: 10.1016/j.neuroscience.2004.09.043.
4
Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma.过氧化物酶体增殖物激活受体α、β/δ和γ对小鼠巨噬细胞泡沫细胞形成及动脉粥样硬化的差异性抑制作用
J Clin Invest. 2004 Dec;114(11):1564-76. doi: 10.1172/JCI18730.
5
Three peroxisome proliferator-activated receptor isotypes from each of two species of marine fish.来自两种海鱼的三种过氧化物酶体增殖物激活受体同种型。
Endocrinology. 2005 Jul;146(7):3150-62. doi: 10.1210/en.2004-1638. Epub 2005 Mar 24.
6
Pharmacological Blockade of PPAR Isoforms Increases Conditioned Fear Responding in the Presence of Nociceptive Tone.过氧化物酶体增殖物激活受体亚型的药理学阻断在存在伤害性刺激时会增加条件性恐惧反应。
Molecules. 2020 Feb 24;25(4):1007. doi: 10.3390/molecules25041007.
7
The Endocannabinoid System and PPARs: Focus on Their Signalling Crosstalk, Action and Transcriptional Regulation.内源性大麻素系统和过氧化物酶体增殖物激活受体:专注于它们的信号串扰、作用和转录调控。
Cells. 2021 Mar 7;10(3):586. doi: 10.3390/cells10030586.
8
[PPARs: physiological functions and pharmacological roles of agonists in human diseases. Note II].[过氧化物酶体增殖物激活受体:激动剂在人类疾病中的生理功能及药理作用。注释II]
Rev Med Chir Soc Med Nat Iasi. 2012 Jan-Mar;116(1):240-7.
9
A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis.过氧化物酶体增殖物激活受体(PPARs)之间的相互作用协同促使C6胶质瘤细胞分化为少突胶质细胞,并诱导参与髓鞘合成的酶。
J Cell Physiol. 2008 Nov;217(2):367-76. doi: 10.1002/jcp.21509.
10
Inflammatory reaction versus endogenous peroxisome proliferator-activated receptors expression, re-exploring secondary organ complications of spontaneously hypertensive rats.炎症反应与内源性过氧化物酶体增殖物激活受体表达:对自发性高血压大鼠继发性器官并发症的再探索
Chin Med J (Engl). 2008 Nov 20;121(22):2305-11.

引用本文的文献

1
Intensity, Duration, and Context Dependency of the Responses to Nutrient Surplus and Deprivation Signaling in the Heart: Insights Into the Complexities of Cardioprotection.心脏对营养过剩和营养缺乏信号反应的强度、持续时间及背景依赖性:对心脏保护复杂性的见解
Circulation. 2025 Sep 16;152(11):802-835. doi: 10.1161/CIRCULATIONAHA.125.075568. Epub 2025 Sep 15.
2
PPARG governs adipogenic differentiation and cell state plasticity in well-differentiated and dedifferentiated liposarcoma.PPARG在高分化和去分化脂肪肉瘤中调控脂肪生成分化和细胞状态可塑性。
bioRxiv. 2025 Jul 21:2025.07.16.665211. doi: 10.1101/2025.07.16.665211.
3

本文引用的文献

1
Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future.噻唑烷二酮类药物治疗 2 型糖尿病:过去、现在和未来。
Crit Rev Toxicol. 2018 Jan;48(1):52-108. doi: 10.1080/10408444.2017.1351420. Epub 2017 Aug 17.
2
Distinct but complementary contributions of PPAR isotypes to energy homeostasis.过氧化物酶体增殖物激活受体(PPAR)各亚型对能量稳态具有独特但互补的作用。
J Clin Invest. 2017 Apr 3;127(4):1202-1214. doi: 10.1172/JCI88894.
3
The Positive Regulation of eNOS Signaling by PPAR Agonists in Cardiovascular Diseases.
Nuclear receptors in health and disease: signaling pathways, biological functions and pharmaceutical interventions.
健康与疾病中的核受体:信号通路、生物学功能及药物干预
Signal Transduct Target Ther. 2025 Jul 28;10(1):228. doi: 10.1038/s41392-025-02270-3.
4
CGKRK-targeted lipid nanoparticles enhance rosiglitazone delivery to the placenta to ameliorate murine preeclampsia.靶向CGKRK的脂质纳米颗粒增强罗格列酮向胎盘的递送,以改善小鼠先兆子痫。
iScience. 2025 Jul 2;28(8):112744. doi: 10.1016/j.isci.2025.112744. eCollection 2025 Aug 15.
5
Adipose tissue dysfunction disrupts metabolic homeostasis: mechanisms linking fat dysregulation to disease.脂肪组织功能障碍破坏代谢稳态:将脂肪调节异常与疾病联系起来的机制。
Front Endocrinol (Lausanne). 2025 Jun 24;16:1592683. doi: 10.3389/fendo.2025.1592683. eCollection 2025.
6
Disrupting lipid homeostasis with CAV2 in OSCC triggers apoptosis, lipolysis, and mitochondrial dysfunction by transcriptional repression of PPARγ.在口腔鳞状细胞癌中,通过CAV2破坏脂质稳态会通过PPARγ的转录抑制触发细胞凋亡、脂解作用和线粒体功能障碍。
Cell Biosci. 2025 May 14;15(1):59. doi: 10.1186/s13578-025-01399-6.
7
The Placenta Regulates Intrauterine Fetal Growth via Exosomal PPARγ.胎盘通过外泌体PPARγ调节子宫内胎儿生长。
Adv Sci (Weinh). 2025 Apr;12(15):e2404983. doi: 10.1002/advs.202404983. Epub 2025 Feb 14.
8
Multi-omics analysis and experimental verification reveal testicular fatty acid metabolism disorder in non-obstructive azoospermia.多组学分析与实验验证揭示非梗阻性无精子症患者睾丸脂肪酸代谢紊乱
Zool Res. 2025 Jan 18;46(1):177-192. doi: 10.24272/j.issn.2095-8137.2024.223.
9
Thiazolidinedione derivatives in cancer therapy: exploring novel mechanisms, therapeutic potentials, and future horizons in oncology.噻唑烷二酮衍生物在癌症治疗中的应用:探索肿瘤学中的新机制、治疗潜力及未来前景
Naunyn Schmiedebergs Arch Pharmacol. 2025 May;398(5):4705-4725. doi: 10.1007/s00210-024-03661-z. Epub 2024 Dec 2.
10
The Versatile Role of Peroxisome Proliferator-Activated Receptors in Immune-Mediated Intestinal Diseases.过氧化物酶体增殖物激活受体在免疫介导的肠道疾病中的多功能作用。
Cells. 2024 Oct 12;13(20):1688. doi: 10.3390/cells13201688.
过氧化物酶体增殖物激活受体激动剂对心血管疾病中内皮型一氧化氮合酶信号通路的正向调节作用
Am J Cardiovasc Drugs. 2017 Aug;17(4):273-281. doi: 10.1007/s40256-017-0220-9.
4
WIP1 phosphatase is a critical regulator of adipogenesis through dephosphorylating PPARγ serine 112.WIP1磷酸酶通过使PPARγ丝氨酸112去磷酸化,成为脂肪生成的关键调节因子。
Cell Mol Life Sci. 2017 Jun;74(11):2067-2079. doi: 10.1007/s00018-016-2450-4. Epub 2017 Feb 8.
5
Mice with hyperbilirubinemia due to Gilbert's syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPARα.由于吉尔伯特综合征多态性导致高胆红素血症的小鼠,通过降低过氧化物酶体增殖物激活受体α(PPARα)丝氨酸73位点的磷酸化,对肝脂肪变性具有抗性。
Am J Physiol Endocrinol Metab. 2017 Apr 1;312(4):E244-E252. doi: 10.1152/ajpendo.00396.2016. Epub 2017 Jan 17.
6
Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome.合成及天然过氧化物酶体增殖物激活受体(PPAR)激动剂作为代谢综合征的治疗候选药物。
Expert Opin Ther Targets. 2017 Mar;21(3):333-348. doi: 10.1080/14728222.2017.1280467. Epub 2017 Jan 25.
7
Browning of White Adipose Tissue with Roscovitine Induces a Distinct Population of UCP1 Adipocytes.用罗斯考维汀诱导白色脂肪组织褐变可产生独特的解偶联蛋白1脂肪细胞群体。
Cell Metab. 2016 Dec 13;24(6):835-847. doi: 10.1016/j.cmet.2016.10.005.
8
Ubiquitin Ligase NEDD4 Regulates PPARγ Stability and Adipocyte Differentiation in 3T3-L1 Cells.泛素连接酶 NEDD4 调节 3T3-L1 细胞中 PPARγ 的稳定性和脂肪细胞分化。
Sci Rep. 2016 Dec 5;6:38550. doi: 10.1038/srep38550.
9
Biliverdin Reductase A Attenuates Hepatic Steatosis by Inhibition of Glycogen Synthase Kinase (GSK) 3β Phosphorylation of Serine 73 of Peroxisome Proliferator-activated Receptor (PPAR) α.胆红素还原酶A通过抑制糖原合酶激酶(GSK)3β对过氧化物酶体增殖物激活受体(PPAR)α丝氨酸73的磷酸化来减轻肝脏脂肪变性。
J Biol Chem. 2016 Nov 25;291(48):25179-25191. doi: 10.1074/jbc.M116.731703. Epub 2016 Oct 10.
10
PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD.过氧化物酶体增殖物激活受体在肥胖诱导的 2 型糖尿病、血脂异常和非酒精性脂肪性肝病中的作用。
Nat Rev Endocrinol. 2017 Jan;13(1):36-49. doi: 10.1038/nrendo.2016.135. Epub 2016 Sep 16.